Cargando…
The Regulatory Environment of Telemedicine After COVID-19
The COVID-19 pandemic has created many barriers to providing health care, yet it also has created new opportunities. Although telemedicine was a nascent means of health care delivery before COVID-19, it now is one of the principal means for doing so today, and it is likely to remain so. Whether this...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Academy of Allergy, Asthma & Immunology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277986/ https://www.ncbi.nlm.nih.gov/pubmed/35842133 http://dx.doi.org/10.1016/j.jaip.2022.07.001 |
_version_ | 1784746103140253696 |
---|---|
author | Pandya, Aarti Waller, Morgan Portnoy, Jay M. |
author_facet | Pandya, Aarti Waller, Morgan Portnoy, Jay M. |
author_sort | Pandya, Aarti |
collection | PubMed |
description | The COVID-19 pandemic has created many barriers to providing health care, yet it also has created new opportunities. Although telemedicine was a nascent means of health care delivery before COVID-19, it now is one of the principal means for doing so today, and it is likely to remain so. Whether this will happen may depend in part on continued relaxation of regulations that hampered it before the pandemic. Whereas enforcement of compliance with Health Information Portability and Accountability Act will most likely resume, platform operators and providers have had an opportunity to prepare for this. State licensure requirements may also resume; however, the regulations were in the process of becoming more liberal before COVID-19 so that process might continue. There is no reason to anticipate that payment for telemedicine services including check-ins, remote physiologic and therapeutic monitoring, and relaxation of location and service requirements will end. For these reasons, telemedicine therefore is likely to continue as an important part of medical practice. |
format | Online Article Text |
id | pubmed-9277986 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Academy of Allergy, Asthma & Immunology |
record_format | MEDLINE/PubMed |
spelling | pubmed-92779862022-07-14 The Regulatory Environment of Telemedicine After COVID-19 Pandya, Aarti Waller, Morgan Portnoy, Jay M. J Allergy Clin Immunol Pract Review and Feature Article The COVID-19 pandemic has created many barriers to providing health care, yet it also has created new opportunities. Although telemedicine was a nascent means of health care delivery before COVID-19, it now is one of the principal means for doing so today, and it is likely to remain so. Whether this will happen may depend in part on continued relaxation of regulations that hampered it before the pandemic. Whereas enforcement of compliance with Health Information Portability and Accountability Act will most likely resume, platform operators and providers have had an opportunity to prepare for this. State licensure requirements may also resume; however, the regulations were in the process of becoming more liberal before COVID-19 so that process might continue. There is no reason to anticipate that payment for telemedicine services including check-ins, remote physiologic and therapeutic monitoring, and relaxation of location and service requirements will end. For these reasons, telemedicine therefore is likely to continue as an important part of medical practice. American Academy of Allergy, Asthma & Immunology 2022-10 2022-07-13 /pmc/articles/PMC9277986/ /pubmed/35842133 http://dx.doi.org/10.1016/j.jaip.2022.07.001 Text en © 2022 American Academy of Allergy, Asthma & Immunology. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Review and Feature Article Pandya, Aarti Waller, Morgan Portnoy, Jay M. The Regulatory Environment of Telemedicine After COVID-19 |
title | The Regulatory Environment of Telemedicine After COVID-19 |
title_full | The Regulatory Environment of Telemedicine After COVID-19 |
title_fullStr | The Regulatory Environment of Telemedicine After COVID-19 |
title_full_unstemmed | The Regulatory Environment of Telemedicine After COVID-19 |
title_short | The Regulatory Environment of Telemedicine After COVID-19 |
title_sort | regulatory environment of telemedicine after covid-19 |
topic | Review and Feature Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277986/ https://www.ncbi.nlm.nih.gov/pubmed/35842133 http://dx.doi.org/10.1016/j.jaip.2022.07.001 |
work_keys_str_mv | AT pandyaaarti theregulatoryenvironmentoftelemedicineaftercovid19 AT wallermorgan theregulatoryenvironmentoftelemedicineaftercovid19 AT portnoyjaym theregulatoryenvironmentoftelemedicineaftercovid19 AT pandyaaarti regulatoryenvironmentoftelemedicineaftercovid19 AT wallermorgan regulatoryenvironmentoftelemedicineaftercovid19 AT portnoyjaym regulatoryenvironmentoftelemedicineaftercovid19 |